1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) Financials

ANGN

Angion Biomedica Corporation
0.5431
0.00 (0.0%)
Upgrade to Real-Time

Angion Biomedica Corp. (ANGN) Fundamentals
Angion Biomedica Corp is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Its product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic that is evaluating in multiple acute organ injuries and related indications, including acute kidney injury (AKI) and injuries to other major organs, such as the lungs, central nervous system (CNS) and heart; acute lung injury (ALI), with primary focus on acute respiratory distress syndrome (ARDS), and acute CNS injuries. It is advancing multiple programs for the treatment of fibrotic diseases, leading with ANG-3070, a tyrosine kinase inhibitor (TKI), and inhibitor of rho kinase 2 (ROCK2).
SHARE INFORMATION
Market CapUS$ 15,659,379
Shares Outstanding30,114,190
Float25,891,110
Percent Float85.98%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 2,301,000
Latest Fiscal EPSUS$ -1.29
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions120
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months135,462
Institutional Holdings Percent23.6%
Institutional Sold Previous 3 Months1,972,214
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent22.8
Insider Sold Previous 3 Months-
Insider Shares Owned4,048,264
TRADING INFO
52 Week HighUS$ 2.41
52 Week LowUS$ 0.46
52 Week High ChangeUS$ -73.60
21 Day Moving AverageUS$ 0.5855
21 Day Extended Moving AverageUS$ 0.574276
50 Day Moving AverageUS$ 0.6627
50 Day Extended Moving AverageUS$ 0.653201
200 Day Moving AverageUS$ 0.958763
200 Day Extended Moving AverageUS$ 1.332
10 Day Average Volume27,278
20 Day Average Volume25,051
30 Day Average Volume32,419
50 Day Average Volume72,444
Alpha-0.107486
Beta0.5453
Standard Deviation0.197808
R20.023486
7 Day Price ChangeUS$ 0.0157
7 Day Percent Change3.11%
21 Day Price ChangeUS$ -0.0819
21 Day Percent Change-13.61%
30 Day Price ChangeUS$ -0.13
30 Day Percent Change-20.0%
Month to Date Price ChangeUS$ -0.12
Month to Date Percent Change-18.75%
Quarter to Date Price ChangeUS$ -0.2916
Quarter to Date Percent Change-35.93%
180 Day Price ChangeUS$ -0.4148
180 Day Percent Change-44.37%
200 Day Price ChangeUS$ -0.4744
200 Day Percent Change-47.71%
Year to Date Price ChangeUS$ -0.2916
Year to Date Percent Change-35.93%

Angion Biomedica Corp. (ANGN) Key Ratios

PROFITABILITY
EBIT Margin-42.1%
EBITDA Margin-38.7%
Pre-Tax Profit Margin-1,528.4%
Profit Margin Count-75.02%
Gross Margin100.0%
Profit Margin TOT-75.02%
INCOME STATEMENTS
RevenueUS$ 2,301,000
Revenue Per ShareUS$ 0.0764
Revenue (3 Years)US$ 20.93
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.30
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio8.10
Leverage Ratio1.20
Quick Ratio8.00
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-1.30
Enterprise ValueUS$ -32,021,047
Price to Sales6.8055
Price to Free Cash-0.40
PE High Last 5 Years0.00
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.30
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-53.96
Return on Equity-64.33
Return on Capital-28.36

Angion Biomedica Corp. (ANGN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorMoss Adams LLP
CEOJay Venkatesan
Emplyoees39
Last AuditUQ
CIK0001601485
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address51 Charles Lindbergh Boulevard
Suite 14
Uniondale, NY 11553
Websitehttps://www.angion.com
Facsimile-
Telephone+1 415 655-4899
Email-
Your Recent History
NASDAQ
ANGN
Angion Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230324 09:09:36